ctrl K

Price Alert

Cyclerion Therapeutics In... (CYCN)

NASDAQ: CYCN · Real-Time Price · USD

2.51

0.11 (4.59%)

At close: Aug 18, 2025, 3:45 PM

2.49

-0.80%

After-hours: Aug 18, 2025, 04:36 PM EDT

Cyclerion Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.23M	7.57M	13.38M	53.96M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	5.35M	5.35M	n/a	n/a
Other Long-Term Assets	n/a	n/a	2.04M	2.41M
Receivables	556K	n/a	96K	100K
Inventory	n/a	n/a	805K	928K
Other Current Assets	16K	11K	537K	468K
Total Current Assets	4.22M	8.02M	14.82M	55.46M
Property-Plant & Equipment	n/a	n/a	1.22M	1.47M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.35M	5.35M	3.26M	3.87M
Total Assets	9.57M	13.37M	18.08M	59.33M
Account Payables	390K	1.2M	2.97M	1.83M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	63K	102K	3.99M	7.28M
Total Current Liabilities	725K	2.09M	7.63M	11.09M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	2.97M	n/a
Total Liabilities	725K	2.09M	7.63M	11.09M
Total Debt	n/a	n/a	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a
Retained Earnings	-267.49M	-264.42M	-259.15M	-215.08M
Comprehensive Income	n/a	-12K	-20K	-23K
Shareholders Equity	8.85M	11.29M	10.45M	48.25M
Total Investments	5.35M	5.35M	n/a	n/a